4D Molecular Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/07/2025 | 4.92 M | $27.41 M | 1.08% | 8.86% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 4.56 M | $25.42 M | -10.49% | 8.21% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 4.27 M | $23.81 M | 19.05% | 7.70% |
| VR ADVISER, LLC | 02/14/2025 | 2.95 M | $16.44 M | -32.90% | 5.31% |
| VANGUARD GROUP INC | 02/11/2025 | 2.86 M | $15.93 M | 3.35% | 5.15% |
| BVF INC/IL | 02/14/2025 | 2.67 M | $14.88 M | -63.83% | 4.81% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 2.25 M | $12.54 M | -28.21% | 4.05% |
| MORGAN STANLEY | 02/14/2025 | 1.86 M | $10.38 M | 9.44% | 3.35% |
| NOVO HOLDINGS A/S | 02/14/2025 | 1.50 M | $8.36 M | 0.00% | 2.70% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.42 M | $7.91 M | 1,607.07% | 2.56% |
| BRAIDWELL LP | 02/14/2025 | 1.23 M | $6.83 M | 0.00% | 2.21% |
| REDMILE GROUP, LLC | 02/14/2025 | 1.20 M | $6.67 M | -5.16% | 2.15% |
| CASDIN CAPITAL, LLC | 02/14/2025 | 1.15 M | $6.41 M | 0.00% | 2.07% |
| STATE STREET CORP | 02/14/2025 | 1.11 M | $6.20 M | -47.43% | 2.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.01 M | $5.64 M | -2.35% | 1.82% |
| JPMORGAN CHASE & CO | 02/12/2025 | 820,069 | $4.57 M | 159.53% | 1.48% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 794,598 | $4.43 M | -1.11% | 1.43% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 653,530 | $3.64 M | -57.66% | 1.18% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 609,900 | $3.40 M | -85.11% | 1.10% |
| CITADEL ADVISORS LLC | 02/14/2025 | 605,092 | $3.37 M | 374.03% | 1.09% |
| NORGES BANK | 02/12/2025 | 500,823 | $2.79 M | 100.00% | 0.90% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 02/14/2025 | 459,000 | $2.56 M | 0.00% | 0.83% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 448,831 | $2.50 M | 2,084.52% | 0.81% |
| NORTHERN TRUST CORP | 02/14/2025 | 440,665 | $2.45 M | 2.32% | 0.79% |
| DECHENG CAPITAL LLC | 02/14/2025 | 400,000 | $2.23 M | 0.54% | 0.72% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 384,880 | $2.14 M | 3,144.92% | 0.69% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 313,993 | $1.75 M | 196.30% | 0.57% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 308,609 | $1.72 M | -8.78% | 0.56% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 300,000 | $1.67 M | -10.71% | 0.54% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 241,853 | $1.35 M | -69.87% | 0.44% |
| JANE STREET GROUP, LLC | 02/14/2025 | 210,824 | $1.17 M | 44.88% | 0.38% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 183,899 | $1.02 M | -36.59% | 0.33% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 177,279 | $987,444 | 6.67% | 0.32% |
| ALGERT GLOBAL LLC | 02/14/2025 | 176,778 | $985,000 | 140.72% | 0.32% |
| ENGINEERS GATE MANAGER LP | 02/14/2025 | 171,422 | $954,821 | 187.60% | 0.31% |
| PERIGON WEALTH MANAGEMENT, LLC | 01/22/2025 | 146,133 | $683,902 | -0.03% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 145,941 | $812,892 | -0.32% | 0.26% |
| 01/29/2025 | 144,743 | $806,219 | 100.00% | 0.26% | |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 131,965 | $734,607 | -36.80% | 0.24% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 126,400 | $704,048 | 451.97% | 0.23% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 123,468 | $687,717 | 0.00% | 0.22% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/11/2025 | 121,000 | $673,970 | 22.84% | 0.22% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 112,904 | $628,875 | 100.00% | 0.20% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 106,530 | $593,372 | -33.95% | 0.19% |
| BARCLAYS PLC | 02/13/2025 | 105,245 | $586,000 | -8.36% | 0.19% |
| UBS GROUP AG | 02/14/2025 | 97,564 | $543,431 | 21.52% | 0.18% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 95,424 | $531,512 | 100.00% | 0.17% |
| JUMP FINANCIAL, LLC | 02/13/2025 | 94,689 | $527,418 | 25.43% | 0.17% |
| CITIGROUP INC | 02/12/2025 | 93,621 | $521,469 | 3.56% | 0.17% |
| HRT FINANCIAL LP | 02/14/2025 | 83,419 | $464,000 | 100.00% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
4D Molecular Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 163 institutional investors and hedge funds held shares of 4D Molecular Therapeutics, Inc.. The most heavily invested institutionals were:
Marquette Asset Management, LLC: 0
Farther Finance Advisors, LLC: 0
BlackRock, Inc.: 4.92 M
RA CAPITAL MANAGEMENT, L.P.: 4.56 M
GOLDMAN SACHS GROUP INC: 4.27 M
VR Adviser, LLC: 2.95 M
84.35% of 4D Molecular Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 50.82 M shares in the last 24 months. This purchase volume represents approximately $151.43 M in transactions.